- Glow Lifetech (CSE:GLOW) posted its 12th consecutive quarter of year-over-year revenue growth in Q2 2026.
- The Canadian-based biotechnology company offers nutraceutical and cannabinoid-based products.
- Glow Lifetech stock has given back 35.71 per cent year-over-year and 80.43 per cent since 2021.
Glow Lifetech (CSE:GLOW) posted its 12th consecutive quarter of year-over-year (YoY) revenue growth in Q2 2026, supported by high gross margins and positive cash flow from operations, setting a firm foundation for long-term shareholder value.
This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
Financial highlights
- Net revenue of C$522,968, up by 20 per cent YoY.
- Gross profit of C$328,309, up by 12 per cent YoY.
- Gross margin of 63 per cent, down from 67 per cent YoY, reflecting a balance between scaling the business and growing demand for larger-format, higher-margin SKUs.
- Total expenses of C$481,490, down by 29 per cent YoY.
- Cash flow from operations of C$3,852, up from a C$31,154 loss YoY.
- EBITDA loss of C$89,145, a 46 per cent improvement YoY.
- Cash position of C$1,595,479, up by 51 per cent YoY, and a working capital surplus of C$1,806,578.
- Current ratio of 2.62x, up from 2.24x YoY, granting the company flexibility to pursue growth initiatives.
- Warrants overhang completely eliminated, following the expiration of the remaining 8.9 million warrants during the quarter and more than 70 million warrants cancelled over the past three quarters.
Operational highlights
- Market expansion: In April 2026, Glow expanded the distribution of its MOD brand into two of Canada’s largest cannabis retailers, adding about 140 new retail locations across Ontario.
- New launches: In May 2026, the company launched MOD fast-acting, water-soluble CBD drops, following this up in July with .decimal live resin THC capsules, a powder-based formulation in a 10 mg format.
- Expansion into Quebec: In August 2026, Glow introduced itself to the Quebec cannabis market, one of the largest in Canada, with three SKUs from its .decimal brand.
Outlook
According to Tuesday’s news release, backed by a stronger balance sheet, incremental operational efficiency and expanding national distribution, Glow is in an optimal position to continue scaling its business in line with shareholder value.
Leadership commentary
“Q2 was another important quarter for Glow, delivering 20 per cent YoY revenue growth, our 12th consecutive quarter of YoY growth, positive operating cash flow, and a 29 per cent reduction in total expenses, while maintaining strong gross margins,” Rob Carducci, Chief Executive Officer of Glow Lifetech, said in a statement. “Importantly, we delivered these results while further strengthening the foundation of the business, including the full elimination of our warrant overhang and continued improvement in operating efficiency. As we enter the second half of 2026, Glow is positioned with a stronger balance sheet, a cleaner capital structure and an expanding national distribution platform. With recent product innovation, expanded penetration with leading retailers and our recent entry into Quebec now underway, we believe the company is well-positioned for the next phase of growth while remaining focused on disciplined execution, sustainable profitability and long-term value creation for shareholders.”
About Glow Lifetech
Glow Lifetech is a Canadian-based biotechnology company offering nutraceutical and cannabinoid-based products. These are highlighted by its MyCell delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates.
Glow Lifetech stock (CSE:GLOW) is unchanged trading at C$0.045 as of 9:34 am ET. The stock has given back 35.71 per cent year-over-year and 80.43 per cent since 2021.
Join the discussion: Find out what investors are saying about this biotechnology and cannabis stock on the Glow Lifetech Corp. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.
